Ticker
ACRX

Price
1.13
Stock movement up
+0.03 (2.52%)
Company name
AcelRx Pharmaceuticals Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Drug Manufacturers-Specialty & Generic
Market cap
9.25M
Ent value
17.28M
Price/Sales
6.08
Price/Book
0.34
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
0.20
Forward P/E
-
PEG
-
EPS growth
-21.01%
1 year return
-4.43%
3 year return
-69.20%
5 year return
-55.04%
10 year return
-41.97%
Last updated: 2024-03-27

DIVIDENDS

ACRX does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E0.20
Price to OCF-
Price to FCF-
Price to EBITDA0.19
EV to EBITDA0.35

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales6.08
Price to Book0.34
EV to Sales11.36

FINANCIALS

Per share

Loading...
Per share data
Current share count8.20M
EPS (TTM)6.41
FCF per share (TTM)-4.24

Income statement

Loading...
Income statement data
Revenue (TTM)1.52M
Gross profit (TTM)-1.94M
Operating income (TTM)-37.38M
Net income (TTM)47.32M
EPS (TTM)6.41
EPS (1y forward)-2.93

Margins

Loading...
Margins data
Gross margin (TTM)-127.68%
Operating margin (TTM)-2457.26%
Profit margin (TTM)3111.24%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash12.73M
Net receivables512.00K
Total current assets24.54M
Goodwill0.00
Intangible assets8.82M
Property, plant and equipment0.00
Total assets48.31M
Accounts payable2.00M
Short/Current long term debt12.47M
Total current liabilities15.65M
Total liabilities20.77M
Shareholder's equity27.54M
Net tangible assets27.23M

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-30.92M
Capital expenditures (TTM)344.00K
Free cash flow (TTM)-31.27M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity171.82%
Return on Assets97.95%
Return on Invested Capital128.64%
Cash Return on Invested Capital-84.99%

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open1.14
Daily high1.21
Daily low1.08
Daily Volume90K
All-time high262.40
1y analyst estimate80.00
Beta0.27
EPS (TTM)6.41
Dividend per share-
Ex-div date-
Next earnings date28 Mar 2024

Downside potential

Loading...
Downside potential data
ACRXS&P500
Current price drop from All-time high-99.57%-
Highest price drop-99.82%-56.47%
Date of highest drop13 Nov 20239 Mar 2009
Avg drop from high-67.08%-11.36%
Avg time to new high126 days13 days
Max time to new high2678 days1805 days
COMPANY DETAILS
ACRX (AcelRx Pharmaceuticals Inc) company logo
Marketcap
9.25M
Marketcap category
Small-cap
Description
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed and patient-controlled analgesia system that allows hospital patients with moderate-to-severe acute pain to self-dose with sufentanil sublingual tablets to manage their pain; ARX-02, which is in Phase 2 clinical trial for the treatment of cancer breakthrough pain in opioid-tolerant patients; and 4ARX-03 for mild sedation and pain relief during painful procedures. Its product candidates also include Niyad, a regional anticoagulant for the extracorporeal circuit; and LTX-608, a nafamostat formulation for direct IV infusion being explored as an investigational product for antiviral treatment of COVID, acute respiratory distress syndrome, disseminated intravascular coagulation, and acute pancreatitis. The company was formerly known as SuRx, Inc. and changed its name to AcelRx Pharmaceuticals, Inc. in August 2006. AcelRx Pharmaceuticals, Inc. was incorporated in 2005 and is based in Hayward, California.
Employees
20
Investor relations
-
SEC filings
CEO
Vincent J. Angotti
Country
USA
City
Redwood City
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner